COMP <GO>
ADT vs PG // ALTMAN Z-SCORE & DEBT/EQUITY
ADT Inc. (NYSE) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: ADT 7
— PG 7
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: PG
LAST: $9.86 (-0.10%) • MKT CAP: $7.21B
balance-sheet
0.69
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
balance-sheet
5.59
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ADT VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ADT | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 51.20% | -10.20 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.30% | 25.40% | -16.10 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.9x | 16.2x | -6.30 | ADT | /valuation <GO> |
| Free Cash Flow Yield | 22.00% | 3.77% | +18.23 | ADT | /fcf-yield <GO> |
| Operating Margin | 25.50% | 24.30% | +1.20 | ADT | /operating-margins <GO> |
| Net Profit Margin | 11.60% | 19.00% | -7.40 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 4.70% | 0.30% | +4.40 | ADT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.59% | 2.65% | -0.06 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 0.69 | 5.59 | -4.90 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 6.50% | +0.60 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 88.3 | 62.7 | +25.61 | ADT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 0.87 | +0.18 | ADT | /macro-sensitivity <GO> |
| Forward P/E Multiple | 11.3x | 21.7x | -10.40 | ADT | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.21B | $372.21B | -$365.00B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ADT REV | PG REV | ADT GROSS % | PG GROSS % | ADT FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.13B | $84.28B | 44.0% | 51.2% | $1.71B | $14.04B |
| FY 2024 | $4.90B | $84.04B | 44.0% | 51.4% | $1.72B | $16.52B |
| FY 2023 | $4.65B | $82.01B | 44.0% | 44.0% | $1.45B | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ADT // BETA 1.05
PG // BETA 0.87